Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Axogen (AXGN) Accumulated Expenses (2016 - 2020)

Historic Accumulated Expenses for Axogen (AXGN) over the last 11 years, with Q3 2020 value amounting to $9.7 million.

  • Axogen's Accumulated Expenses rose 2198.84% to $9.7 million in Q3 2020 from the same period last year, while for Sep 2020 it was $9.7 million, marking a year-over-year increase of 2198.84%. This contributed to the annual value of $7.6 million for FY2019, which is 1781.69% up from last year.
  • Axogen's Accumulated Expenses amounted to $9.7 million in Q3 2020, which was up 2198.84% from $6.1 million recorded in Q2 2020.
  • Over the past 5 years, Axogen's Accumulated Expenses peaked at $9.7 million during Q3 2020, and registered a low of $1.3 million during Q1 2016.
  • For the 5-year period, Axogen's Accumulated Expenses averaged around $4.6 million, with its median value being $3.9 million (2017).
  • In the last 5 years, Axogen's Accumulated Expenses skyrocketed by 7588.84% in 2017 and then soared by 98.99% in 2020.
  • Axogen's Accumulated Expenses (Quarter) stood at $2.6 million in 2016, then soared by 52.62% to $3.9 million in 2017, then skyrocketed by 64.27% to $6.5 million in 2018, then increased by 17.82% to $7.6 million in 2019, then increased by 26.86% to $9.7 million in 2020.
  • Its Accumulated Expenses stands at $9.7 million for Q3 2020, versus $6.1 million for Q2 2020 and $5.3 million for Q1 2020.